MedTrace Logo

Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis

NCT06542965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2024-08-07

No results posted yet for this study

Summary

This study aims to determine the clinical characteristics, risk factors, and resistance mechanisms of patients with carbapenem-resistant P. mirabilis bacteremia.Patients with P. mirabilis growth in blood culture samples sent to bacteriology laboratory between 2018 and 2021 were retrospectively analyzed. Patients meeting the inclusion criteria were divided into carbapenem-resistant and carbapenem- susceptible groups. The investigators recorded demographic data, clinical features, and laboratory findings. Resistance genes were investigated in carbapenem-resistant isolates using PCR.

Conditions

  • Proteus Mirabilis Infection
  • Bacteremia
  • Carbapenem Resistant Bacterial Infection

Interventions

OTHER

Non-Interventional Research

Non-Interventional Research

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Çağlar IRMAK · Dokuz Eylul University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-12-31
Completion
2023-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06542965 on ClinicalTrials.gov